期刊文献+

冠心病患者血清中SFRP5水平及临床意义 被引量:8

Clinical significance of serum SFRP5 levels in patients with coronary heart disease
下载PDF
导出
摘要 目的探讨冠状动脉粥样硬化性心脏病(冠心病)患者血清中分泌型卷曲蛋白5(SFRP5)水平及临床意义。方法选择2015年1月~2015年10月于大连医科大学附属大连市中心医院收治的冠心病患者97例为观察组,另选同期非冠心病患者45例为对照组,采用SYNTAX评分评价所有患者冠状动脉病变程度,采集血液标本检测血清分泌型卷曲蛋白5(SFRP5)及其它血液生化指标。结果观察组患者体质指数(BMI)、高敏C反应蛋白(hs-CRP)显著高于对照组(P均<0.05),血清低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、总胆固醇(TC)水平显著低于对照组(P均<0.05);观察组患者SFRP5水平为(37.49±4.95),显著低于对照组(t=15.275,P<0.001),急性冠脉综合征(ACS)患者SFRP5水平低于稳定型心绞痛(SAP)患者(P<0.05),ACS患者SYNTAX得分显著高于SAP患者(t=2.042,P=0.044);多元线性回归分析,结果显示SFRP5和hs-CRP与SYNTAX评分呈线性回归关系,且SFRP5的相关程度高于hs-CRP。结论冠心病患者血清SFRP5水平显著降低,并且与冠状动脉病变程度呈负相关。 Objective To explore the changes of serum SFRP5 levels in patients with coronary heart disease(CHD)and its clinical significance.Methods 97 patients with CHD(case group)and 45 cases patients without CHD(control group)from January 2015 to October 2015 in Dalian City Center Hospital Affiliated to Dalian Medical University were recruited as subjects.SYNTAX score was used to evaluate the severity of coronary artery lesions under coronary angiography.The blood samples were collected and serum secreted frizzled-related protein 5(SFRP5)and other blood biochemical parameters were measured.Results The levels of BMI and hs-CRP in the case group were significantly higher than those in control group(all P<0.05),and the serum LDL-C,HDL-C and TC were significantly lower than those of control group(all P<0.05).SFRP5 level(37.49±4.95)in case group was significantly lower than that in control group(t=15.275,P=0.000).The level of SFRP5 in patients with acute coronary syndrome(ACS)is lower than that in stable angina pectoris(SAP)patients(P<0.05).SYNTAX scores of ACS patients were significantly higher than that of patients with SAP(t=2.042,P=0.044).Multiple linear regression analysis showed that SFRP5 and hs-CRP had linear regression relationship with SYNTAX score.Conclusion The f serum SFRP5 level in patients with CHD is significantly decreased,and negatively correlated with the degree of coronary artery disease,suggesting that SFRP5 may be closely related to the occurrence and development of coronary heart disease,which can be used for the diagnosis and prevention of coronary heart disease.
作者 杨雪 智永超 孙卓 田云朋 孙丽丽 Yang Xue;Zhi Yongchao;Sun Zhuo;Tian Yunpeng;Sun Lili(Department of Cardiology,Dalian Municipal Central Hospital Affiliated of Dalian Medical University,Dalian 116033,China)
出处 《中国循证心血管医学杂志》 2018年第7期870-872,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 冠心病 SFRP5 动脉粥样硬化 诊断 Coronary heart disease SFRP5 Atherosclerosis Diagnosis
  • 相关文献

参考文献6

二级参考文献95

  • 1CHANCE研究组.无保护左主干病变支架置入术预后及影响因素的分析——中国无保护左主干病变支架置入术注册(CHANCE)研究[J].中华心血管病杂志,2005,33(3):210-215. 被引量:19
  • 2陆国平,吴志俊,戚文航.他汀类药物与动脉粥样硬化斑块消退[J].中国循环杂志,2007,22(1):69-72. 被引量:25
  • 3Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 4吴焕林,阮新民,杨小波,罗文杰,陈可冀,邓铁涛.319例冠心病患者证候分布规律分析[J].中国中西医结合杂志,2007,27(6):498-500. 被引量:87
  • 5Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 6Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 7Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 8Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 9O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 10Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.

共引文献2935

同被引文献87

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部